Gastric cancer prevention through eradication of helicobacter pylori infection: Feasibility and pitfalls

Archives of Iranian Medicine

Volumn 15, Issue 11, 2012, Pages 662-663

  Derakhshan, Mohammad H ^a   Lee, Yeong Yeh ^a,b  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b SCHOOL OF MEDICAL SCIENCES   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ATROPHIC GASTRITIS; CANCER GROWTH; CANCER INCIDENCE; CANCER PREVENTION; CLINICAL TRIAL (TOPIC); EDITORIAL; ERADICATION THERAPY; FEASIBILITY STUDY; FOLLOW UP; GENETIC VARIABILITY; HELICOBACTER INFECTION; HIGH RISK POPULATION; HUMAN; LIFESTYLE; PEPTIC ULCER; PRECANCER; RISK REDUCTION; SALT INTAKE; SMOKING; STOMACH CANCER; STOMACH CARCINOGENESIS;

HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; STOMACH NEOPLASMS;

EID: 84868238965     PISSN: 10292977     EISSN: 17353947     Source Type: Journal    
DOI: None     Document Type: Editorial

References (21)

1. de Martel C, Ferlay J, Franceschi S, Vignat J, Bray F, Forman D, et al. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol. 2012; 13(6): 607-615.
2. Huang JQ, Sridhar S, Chen Y, Hunt RH. Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer. Gastroenterology. 1998; 114(6): 1169-1179.
3. Correa P, Fontham ET, Bravo JC, Bravo LE, Ruiz B, Zarama G, et al. Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-helicobacter pylori therapy. J Natl Cancer Inst. 2000; 92(23): 1881-1888.
4. Leung WK, Lin SR, Ching JY, To KF, Ng EK, Chan FK, et al. Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication. Gut. 2004; 53(9): 1244-1249.
5. Wong BC, Lam SK, Wong WM, Chen JS, Zheng TT, Feng RE, et al. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA. 2004; 291(2): 187-194.
6. You WC, Brown LM, Zhang L, Li JY, Jin ML, Chang YS, et al. Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions. J Natl Cancer Inst. 2006; 98(14): 974-983.
7. Wong BC, Zhang L, Ma JL, Pan KF, Li JY, Shen L, et al. Effects of selective COX-2 inhibitor and Helicobacter pylori eradication on precancerous gastric lesions. Gut. 2012; 61(6): 812-818.
8. Saito D, Boku N, Fujioka T, Fukuda Y, Matsushima Y, Sasaki N, et al. Impact of H-pylori eradication on gastric cancer prevention: Endoscopic results of the Japanese intervention trial (JITHP-study). A Randomized multi-center trial. Gastroenterology. 2005; 128 (suppl 2): 4.
9. Fukase K, Kato M, Kikuchi S, Inoue K, Uemura N, Okamoto S, et al. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet. 2008; 372(9636): 392-397.
10. Ma JL, Zhang L, Brown LM, Li JY, Shen L, Pan KF, et al. Fifteen-year effects of Helicobacter pylori, garlic, and vitamin treatments on gastric cancer incidence and mortality. J Natl Cancer Inst. 2012; 104(6): 488-492.
11. Fuccio L, Zagari RM, Eusebi LH, Laterza L, Cennamo V, Grilli D, et al. Meta-analysis: can Helicobacter pylori eradication treatment reduce the risk for gastric cancer? Ann Intern Med. 2009; 151(2): 121-128.
12. Derakhskan M.H. Malekzadek R. Watabe H, Yazdanbod A, Fyfe V. Kazemi A. et al. Combination of gastric atrophy, reflux symptoms and histological subtype indicates two distinct aetiologies of gastric cardia cancer. Gut. 2008; 57(3): 298-305.
13. Massairat S, Haj-Shevkholeslami A. Mohamadkhani A. Zendehdel N. Rakhshani N, Stolte M, et al. Precancerous conditions after H. pylori eradication: a randomized double blind study in first degree relatives of eastric cancer patients. Arch Iran Med. 2012; 15(11): 664-669.
14. Wang J, Xu L, Shi R, Huang X, Li SW, Huang Z, et al. Gastric atrophy and intestinal metaplasia before and after Helicobacter pylori eradication: a meta-analysis. Digestion. 2011; 83(4): 253-260.
15. Rokkas T, Pistiolas D, Sechopoulos P, Robotis I, Margantinis G. The long-term impact of Helicobacter pylori eradication on gastric histology: a systematic review and meta-analysis. Helicobacter. 2007; 12(suppl 2): 32-38.
16. Sipponen P. Helicobacter pylori gastritis: epidemiology. J Gastroenterol. 1997; 32(2): 273-277.
17. Sotoudeh M, Derakhshan MH, Abedi-Ardakani B, Nouraie M, Yazdanbod A, Tavangar SM, et al. Critical role of Helicobacter pylori in the pattern of gastritis and carditis in residents of an area with high prevalence of gastric cardia cancer. Dig Dis Sci. 2008; 53(1): 27-33.
18. Uyub AM, Raj SM, Visvanathan R, Nazim M, Aiyar S, Anuar AK, et al. Helicobacter pylori infection in north-eastern peninsular Malaysia. Evidence for an unusually low prevalence. Scand J Gastroenterol. 1994; 29(3): 209-213.
19. Lee YY, Ismail AW, Mustaffa N, Musa KI, Majid NA, Choo, KE, et al. Sociocultural and dietary practices among Malay subjects in the northeastern region of Peninsular Malaysia: a region of low prevalence of Helicobacter pylori infection. Helicobacter. 2012; 17 (1): 54-61.
20. Yeh LY, Raj M, Hassan S, Aziz SA, Othman NH, Mutum SS, et al. Chronic atrophic antral gastritis and risk of metaplasia and dysplasia in an area with low prevalence of Helicobacter pylori. Indian J Gastroenterol. 2009; 28(2): 49-52.
21. Milne AN, Carneiro F, O'Morain C, Offerhaus GJ. Nature meets nurture: molecular genetics of gastric cancer. Hum Genet. 2009; 126(5): 615-628.